CA2347331A1 - Freeze-dried composite materials and processes for the production thereof - Google Patents
Freeze-dried composite materials and processes for the production thereof Download PDFInfo
- Publication number
- CA2347331A1 CA2347331A1 CA002347331A CA2347331A CA2347331A1 CA 2347331 A1 CA2347331 A1 CA 2347331A1 CA 002347331 A CA002347331 A CA 002347331A CA 2347331 A CA2347331 A CA 2347331A CA 2347331 A1 CA2347331 A1 CA 2347331A1
- Authority
- CA
- Canada
- Prior art keywords
- sponge
- collagen
- freeze
- regenerated cellulose
- oxidized regenerated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/044—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/02—Equipment for testing the apparatus
Abstract
The invention provides a sterile freeze-dried sponge, wherein at least 80% by weight of the sponge consists of collagen and oxidized regenerated cellulose in the weight ratio 60:40 to 40:60, wherein the sponge has a dry tensile strength of more than 3N and/or a wet tensile strength of more than 1 N. Preferably, the collagen has a degree of denaturation less than 20% and the sponge is substantially free of chemical cross-links. The invention also provides methods for the manufacture of sponges according to the invention
Claims (22)
1. A sterile freeze-dried sponge, wherein at least 80% by weight of the sponge consists of a mixture of collagen and oxidized regenerated cellulose in the weight ratio 60:40 to 40:60, and wherein the sponge has a dry tensile strength as herein defined of more than 3N.
2. A sterile freeze-dried sponge, wherein at least 80% by weight of the sponge consists of a mixture of collagen and oxidized regenerated cellulose in the weight ratio 60:40 to 40:60, wherein the sponge has a wet tensile strength as herein defined greater than 1 N.
3. A sterile freeze-dried sponge according to claim 1, wherein the sponge is substantially free of chemical cross-links.
4. A sterile freeze-dried sponge according to claim 1, wherein the collagen has a degree of denaturation less than 20%.
5. A sterile freeze-dried sponge according to claim 5, wherein the collagen has a degree of denaturation less than 10%.
6. A sterile freeze-dried sponge according to claim 4, wherein 80% of the oxidized regenerated cellulose fibers by volume are between 20µm and 1000µm in length.
7. A sterile freeze-dried sponge according to claim 6, wherein the mean length of the oxidized regenerated cellulose fibers is from 250 to 450µm.
8. A sterile freeze-dried sponge according to claim 1, wherein the oxidized regenerated cellulose is in the form of fibers, and at least 90% of the fibers by volume are less than 1 mm in length.
9. A sterile freeze-dried sponge according to claim 1, wherein the ratio of collagen to oxidized regenerated cellulose is from 50:50 to 55:45.
10. A sterile freeze-dried sponge according to claim 1, wherein the bioburden (TVC) of the sponge is less than 100 cfu/g, preferably less-than 10 cfu/g, more preferably less than 1 cfu/g.
11. A sterile freeze-dried sponge according to claim 1, wherein the sponge contains from 5 to 15% by weight of water.
12. A sterile freeze-dried sponge according to claim 1, wherein a layer of the sponge of thickness 3mm has an uncompressed absorption capacity of 0.9%
saline of from 15 to 20g/100cm2.
saline of from 15 to 20g/100cm2.
13. A sterile freeze-dried sponge according to claim 1, wherein the sponge has a resorption time under simulated physiological conditions of more than 48 hours.
14. A method of manufacture of a freeze-dried sponge pad comprising the steps of:
providing an acidified paste of purified collagen fibers, wherein the collagen is less than 10% denatured;
providing oxidized regenerated cellulose fibers, wherein at least 80% of said fibers have lengths in the range of 20µm to 1000µm;
combining said collagen and said ORC fibers in a homogeneous aqueous dispersion in a weight ratio of 60:40 to 40:60 collagen:ORC, said aqueous dispersion being acidified to a pH in the range of 2.8 to 3.2 and having a total solids concentration of 0.8 to 1.2% by weight;
pouring said aqueous dispersion into trays to a depth greater than 1 cm;
freezing the dispersion to a temperature below -30°C, followed by a temperature programmed freeze drying and dehydrothermal cross-linking to a final moisture content of 5-15% by weight;
splitting the freeze-dried dispersion to remove surface layers and leave one or more pads; and sterilizing the one or more pads by gamma-irradiation.
providing an acidified paste of purified collagen fibers, wherein the collagen is less than 10% denatured;
providing oxidized regenerated cellulose fibers, wherein at least 80% of said fibers have lengths in the range of 20µm to 1000µm;
combining said collagen and said ORC fibers in a homogeneous aqueous dispersion in a weight ratio of 60:40 to 40:60 collagen:ORC, said aqueous dispersion being acidified to a pH in the range of 2.8 to 3.2 and having a total solids concentration of 0.8 to 1.2% by weight;
pouring said aqueous dispersion into trays to a depth greater than 1 cm;
freezing the dispersion to a temperature below -30°C, followed by a temperature programmed freeze drying and dehydrothermal cross-linking to a final moisture content of 5-15% by weight;
splitting the freeze-dried dispersion to remove surface layers and leave one or more pads; and sterilizing the one or more pads by gamma-irradiation.
15. A method according to claim 14 carried out substantially without the use of any chemical cross-linking agents.
16. A method according to claim 14, wherein the step of providing collagen comprises the following steps:
providing fresh and unswollen splits of bovine corium;
treating the splits with a hypochloride solution to inhibit microbial activity;
treating the corium with a solution containing sodium hydroxide and hydrogen peroxide to swell and sterilize the corium; then treating the corium with a aqueous alkali solution at a pH greater than 12 and temperature less than 50°C for a period of ten-fourteen days; then treating the corium with a aqueous acid solution at a pH of 0.8-1.2 and temperature less than 50°C; then washing the corium, and comminuting the corium with sufficient water to form a paste.
providing fresh and unswollen splits of bovine corium;
treating the splits with a hypochloride solution to inhibit microbial activity;
treating the corium with a solution containing sodium hydroxide and hydrogen peroxide to swell and sterilize the corium; then treating the corium with a aqueous alkali solution at a pH greater than 12 and temperature less than 50°C for a period of ten-fourteen days; then treating the corium with a aqueous acid solution at a pH of 0.8-1.2 and temperature less than 50°C; then washing the corium, and comminuting the corium with sufficient water to form a paste.
17. A method according to claim 14, wherein the step of providing oxidized regenerated cellulose fibers comprising milling an oxidized regenerated cellulose cloth and screening the milled particles to remove particles having size less than 20µm or greater than 1000µm.
18. A method according to claim 14, wherein the step of dispersing the collagen and the ORC comprises the steps of:
adding an acid-swollen collagen/water paste to acidified water;
adding oxidized regenerated cellulose fibers to the acidified water; and homogenizing the resulting mixture.
adding an acid-swollen collagen/water paste to acidified water;
adding oxidized regenerated cellulose fibers to the acidified water; and homogenizing the resulting mixture.
19. A method according to claim 14, wherein the step of freezing is carried out by placing the trays containing the aqueous dispersion onto chilled shelves in a freezer followed by holding the trays at a temperature below -30°C
until the freezing is complete.
until the freezing is complete.
20. A method according to claim 14, wherein the step of freeze drying is carried out with dehydrothermal cross-linking.
21. A method according to claim 14, wherein the step of sterilizing is carried out by gamma-irradiation at a dose of 18-29 KGy.
22. A method according to claim 14, wherein the weight ratio of collagen to oxidized regenerated cellulose is from 50:50 to 55:45 and the pH of the aqueous dispersion is from 2.9 to 3.1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/570,105 | 2000-05-12 | ||
US09/570,105 US6309454B1 (en) | 2000-05-12 | 2000-05-12 | Freeze-dried composite materials and processes for the production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2347331A1 true CA2347331A1 (en) | 2001-11-12 |
CA2347331C CA2347331C (en) | 2010-07-13 |
Family
ID=24278241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2347331A Expired - Lifetime CA2347331C (en) | 2000-05-12 | 2001-05-10 | Freeze-dried composite materials and processes for the production thereof |
Country Status (7)
Country | Link |
---|---|
US (2) | US6309454B1 (en) |
EP (1) | EP1153622B1 (en) |
JP (1) | JP4799758B2 (en) |
AU (1) | AU783184B2 (en) |
CA (1) | CA2347331C (en) |
DE (1) | DE60106322T2 (en) |
GB (1) | GB2362466B (en) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8741335B2 (en) | 2002-06-14 | 2014-06-03 | Hemcon Medical Technologies, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan |
IL159339A0 (en) | 2001-06-14 | 2004-06-01 | Providence Health Sys Oregon | Wound dressing and method for controlling severe, life-threatening bleeding |
US7371403B2 (en) * | 2002-06-14 | 2008-05-13 | Providence Health System-Oregon | Wound dressing and method for controlling severe, life-threatening bleeding |
US20030059460A1 (en) * | 2001-09-27 | 2003-03-27 | Yasuhiko Tabata | Hybrid material for regeneration of living body tissue |
US20050137512A1 (en) * | 2003-12-23 | 2005-06-23 | Campbell Todd D. | Wound dressing and method for controlling severe, life-threatening bleeding |
US8269058B2 (en) * | 2002-06-14 | 2012-09-18 | Hemcon Medical Technologies, Inc. | Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan |
US20070082023A1 (en) * | 2002-06-14 | 2007-04-12 | Hemcon Medical Technologies, Inc. | Supple tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan |
GB2392913B (en) * | 2002-09-11 | 2007-04-04 | Johnson & Johnson Medical Ltd | Wound dressings comprising complexes of oxidised celluloses with silver |
PT1536845E (en) | 2002-09-11 | 2007-06-01 | Johnson & Johnson Medical Ltd | Wound dressing materials comprising complexes of anionic polysaccharides with silver |
US6863924B2 (en) * | 2002-12-23 | 2005-03-08 | Kimberly-Clark Worldwide, Inc. | Method of making an absorbent composite |
WO2004112805A1 (en) * | 2003-06-20 | 2004-12-29 | Johnson & Johnson Medical Limited | Antimicrobial silver comprising silver |
GB2408206B (en) | 2003-11-18 | 2007-11-28 | Johnson & Johnson Medical Ltd | Antioxidant and antimicrobial wound dressing materials |
GB0408492D0 (en) | 2004-04-16 | 2004-05-19 | Univ Strathclyde | Performance measurement of wound dressings |
GB2414021A (en) * | 2004-05-10 | 2005-11-16 | Johnson & Johnson Medical Ltd | Absorbable haemostatic materials |
US9204957B2 (en) | 2005-03-17 | 2015-12-08 | Hemcon Medical Technologies, Inc. | Systems and methods for hemorrhage control and or tissue repair |
AU2015246115B2 (en) * | 2005-03-24 | 2017-11-16 | Xyleco, Inc. | Fibrous materials and composites |
AU2013203464B2 (en) * | 2005-03-24 | 2015-10-08 | Xyleco, Inc. | Fibrous materials and composites |
PL2564931T3 (en) * | 2005-03-24 | 2015-01-30 | Xyleco Inc | Methods of making fibrous materials |
US20150328347A1 (en) | 2005-03-24 | 2015-11-19 | Xyleco, Inc. | Fibrous materials and composites |
US20060286144A1 (en) * | 2005-06-17 | 2006-12-21 | Chunlin Yang | Reinforced collagen scaffold |
GB2433029A (en) * | 2005-12-09 | 2007-06-13 | Ethicon Inc | Wound dressings comprising oxidized cellulose and human recombinant collagen |
WO2007109137A1 (en) | 2006-03-20 | 2007-09-27 | Worcester Polytechnic Institute | Fibrin microthreads |
WO2007139845A2 (en) | 2006-05-23 | 2007-12-06 | Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center | Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ |
RU2374374C1 (en) * | 2006-09-12 | 2009-11-27 | Мидвествако Корпорейшн | Carton containing micro-lamellate cellulose particles |
GB2444232A (en) | 2006-11-30 | 2008-06-04 | Ethicon Inc | Wound dressing compositions comprising cell lysates |
US20090004253A1 (en) * | 2007-06-29 | 2009-01-01 | Brown Laura J | Composite device for the repair or regeneration of tissue |
WO2009134447A1 (en) * | 2008-05-02 | 2009-11-05 | Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center | Wound dressing devices and methods |
US20110274726A1 (en) | 2008-10-06 | 2011-11-10 | Providence Health System - Oregon | Chitosan foam medical devices and methods |
DE102008064510A1 (en) | 2008-12-22 | 2010-06-24 | Paul Hartmann Aktiengesellschaft | Measuring apparatus for vacuum therapy systems for wound treatment |
GB0912009D0 (en) | 2009-07-10 | 2009-08-19 | Univ Strathclyde | Sensor |
CA2793412A1 (en) * | 2010-03-17 | 2011-09-22 | Worcester Polytechnic Institute | Biopolymer microthreads with microscale surface topographies |
DE102010037469A1 (en) * | 2010-09-10 | 2012-03-15 | Gelita Ag | A method of reducing endotoxin content in a collagen-containing material |
GB201116523D0 (en) | 2011-09-23 | 2011-11-09 | Systagenix Wound Man Ip Co Bv | Wound prognosis |
BR112013019563A2 (en) | 2011-01-31 | 2019-09-24 | Systagenix Wound Man Ip Co Bv | methods for wound prognosis, for wound treatment, for predicting whether a patient may be responsive to treatment of a wound that exudes a wound fluid, and for treating a wound that exudes a wound fluid, a device for simultaneously or sequentially measuring the wound. hne and at least 1 mmp levels in a wound fluid sample, diagnostic apparatus, and kit. |
EP2502964A1 (en) * | 2011-03-24 | 2012-09-26 | Molda AG | Method for manufacturing collagen |
US8815832B2 (en) | 2012-05-25 | 2014-08-26 | Ethicon, Inc. | Oxidized regenerated cellulose hemostatic powders and methods of making |
ES2934158T3 (en) | 2015-04-28 | 2023-02-17 | Frank Dicosmo | Bioactive collagen biomaterials and methods for their manufacture |
CN115444968B (en) | 2015-11-06 | 2024-04-05 | 伊西康公司 | Compacting hemostatic cellulose aggregates |
EP3370786B1 (en) | 2015-11-08 | 2021-07-28 | Omrix Biopharmaceuticals Ltd. | Hemostatic mixture of cellulose-based short and long fibers |
EP3386557B1 (en) | 2015-12-11 | 2021-03-31 | LifeCell Corporation | Methods and systems for stiffening of tissue for improved processing |
US10322206B2 (en) | 2016-03-29 | 2019-06-18 | Worcester Polytechnic Institute | Compositions and methods for wound healing |
CN107754005B (en) | 2016-08-15 | 2021-06-15 | 广州倍绣生物技术有限公司 | Hemostatic compositions and methods of making same |
US11413335B2 (en) | 2018-02-13 | 2022-08-16 | Guangzhou Bioseal Biotech Co. Ltd | Hemostatic compositions and methods of making thereof |
CN106421884B (en) * | 2016-12-12 | 2019-09-24 | 西北大学 | The method that two step freezings prepare styptic sponge |
KR102050879B1 (en) | 2017-08-11 | 2019-12-17 | 서울대학교 산학협력단 | Method of preparing short fibers, short fibers prepared by the method and use thereof |
WO2019126368A1 (en) | 2017-12-20 | 2019-06-27 | Kci Usa, Inc. | Dressing including dehydrated placental tissue for wound healing |
US20210330855A1 (en) | 2018-07-16 | 2021-10-28 | Systagenix Wound Management, Limited | Nitric oxide producing collagen/orc dressing |
EP3843680B1 (en) | 2018-08-27 | 2023-10-04 | Systagenix Wound Management, Limited | Material application system for tunneling wounds that allows co-delivery of solutions |
CN109673810B (en) * | 2018-12-20 | 2021-06-01 | 南京农业大学 | Regenerated cellulose-myofibrillar protein gel and preparation method thereof |
WO2020131806A1 (en) | 2018-12-21 | 2020-06-25 | Kci Licensing, Inc. | Wound dressings including pvp-citric acid copolymer |
WO2020261190A1 (en) | 2019-06-28 | 2020-12-30 | Kci Licensing, Inc. | Layered collagen dressing with extended bacteria and biofilm reducing capabilities |
WO2020261189A1 (en) | 2019-06-28 | 2020-12-30 | Systagenix Wound Management, Limited | Collagen polysaccharide wound dressing |
CN115252889B (en) * | 2022-07-15 | 2023-07-25 | 武汉纺织大学 | Oxygen generating stent and preparation method thereof |
Family Cites Families (104)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3157524A (en) * | 1960-10-25 | 1964-11-17 | Ethicon Inc | Preparation of collagen sponge |
GB1195061A (en) * | 1966-05-27 | 1970-06-17 | Fmc Corp | Coated Structures and Methods of Forming Them. |
US3598622A (en) | 1969-02-19 | 1971-08-10 | Cpc International Inc | Alkali treated starch compositions |
US3632350A (en) * | 1970-02-02 | 1972-01-04 | Fmc Corp | Food compositions containing microcrystalline collagen |
US4265233A (en) | 1978-04-12 | 1981-05-05 | Unitika Ltd. | Material for wound healing |
US4412947A (en) | 1979-09-12 | 1983-11-01 | Seton Company | Collagen sponge |
DE2943520C2 (en) * | 1979-10-27 | 1982-05-19 | Fa. Carl Freudenberg, 6940 Weinheim | Process for the production of collagen sponge for medical or cosmetic purposes |
DE8013626U1 (en) | 1980-05-21 | 1980-10-30 | Deutsche Semperit Gmbh, 8000 Muenchen | RUBBER OR PLASTIC PROFILE |
CA1156529A (en) | 1980-06-12 | 1983-11-08 | Fred A. Serravallo | Fibrous collagenous hemostatic-adhesive webs |
DE3037513C2 (en) | 1980-10-03 | 1983-05-05 | Steffan, Wolfgang, 8425 Neustadt | Collagen wound dressing |
DE3105624A1 (en) | 1981-02-16 | 1982-09-02 | Hormon-Chemie München GmbH, 8000 München | MATERIAL FOR SEALING AND HEALING Wounds |
ATE13810T1 (en) | 1981-06-25 | 1985-07-15 | Serapharm Gmbh & Co Kg | ENRICHED PLASMA DERIVES TO ASSIST WOUND CLOSURE AND COVERAGE. |
DE3136808A1 (en) | 1981-09-16 | 1983-03-31 | Bayer Ag, 5090 Leverkusen | TRIAZOLIDINE-3,5-DIONE |
FR2516927B1 (en) | 1981-11-26 | 1986-05-23 | Merieux Fond | PROCESS FOR THE INDUSTRIAL PREPARATION OF COLLAGENIC MATERIALS FROM HUMAN PLACENTARY TISSUES, HUMAN COLLAGENIC MATERIALS OBTAINED, THEIR APPLICATION AS BIOMATERIALS |
DE3212412C2 (en) | 1982-04-02 | 1986-01-02 | Dr. Ruhland Nachf. GmbH, 8425 Neustadt | Tissue-bondable collagen wound dressing |
CA1209475A (en) | 1982-04-12 | 1986-08-12 | Mamerto M. Cruz, Jr. | Hemostatic-adhesive collagen dressing for severed biological surfaces |
US5149332A (en) | 1982-06-30 | 1992-09-22 | Richard R. Walton | Absorbent and cushioning products and their manufacture |
EP0227955A3 (en) | 1982-07-21 | 1987-11-25 | University of Strathclyde | Composite wound dressing |
EP0114887B1 (en) | 1982-08-04 | 1990-11-28 | La Jolla Cancer Research Foundation | Polypeptide |
SE446688C (en) | 1982-09-14 | 1989-08-01 | Magnus Hoeoek | Means for the removal of microorganisms from tissues, which consist of a protein that can be bound to the microorganisms |
DE3248188A1 (en) | 1982-12-27 | 1984-06-28 | Behringwerke Ag, 3550 Marburg | METHOD FOR PRODUCING A COLLAGEN FLEECE |
US4474949A (en) | 1983-05-06 | 1984-10-02 | Personal Products Company | Freeze dried microfibrilar cellulose |
GB2148901A (en) | 1983-10-04 | 1985-06-05 | Johnson & Johnson | Protein/polysaccharide complexes |
US4515637A (en) | 1983-11-16 | 1985-05-07 | Seton Company | Collagen-thrombin compositions |
DE3409372A1 (en) | 1984-03-14 | 1985-09-19 | Dr. Ruhland Nachf. GmbH, 8425 Neustadt | Material for the vitalisation of implant surfaces |
GB8413319D0 (en) | 1984-05-24 | 1984-06-27 | Oliver Roy Frederick | Biological material |
US4626253A (en) | 1984-10-05 | 1986-12-02 | Johnson & Johnson Products, Inc. | Surgical hemostat comprising oxidized cellulose |
US4604346A (en) | 1984-10-09 | 1986-08-05 | Massachusetts Institute Of Technology | Skin-equivalent prepared by the use of punch biopsy |
JPS61122222A (en) | 1984-11-19 | 1986-06-10 | Koken:Kk | Hemostatic agent composed of collagen or gelatin and protamine |
US4600533A (en) | 1984-12-24 | 1986-07-15 | Collagen Corporation | Collagen membranes for medical use |
JPS61253065A (en) | 1985-05-02 | 1986-11-10 | 片倉チツカリン株式会社 | Medical composite material of chitosan derivative and collagen and its production |
DE3522626A1 (en) | 1985-06-25 | 1987-01-08 | Merz & Co Gmbh & Co | SOLUBLE COLLAGEN SPONGE |
CS253042B1 (en) | 1985-09-25 | 1987-10-15 | Maxmilian Mozisek | Haemostatical material |
DE3606265A1 (en) | 1986-02-27 | 1987-09-03 | Roehm Pharma Gmbh | POLYSACCHARID-BASED Wound Dressing As a Carrier Therapeutically Effective, Non-Immobilized Enzymes and with High Absorbency |
NZ222413A (en) | 1986-11-05 | 1991-06-25 | Ethicon Inc | Compositions containing a polypeptide growth factor and a water-soluble cellulose polymer stabiliser |
GB8705985D0 (en) | 1987-03-13 | 1987-04-15 | Geistlich Soehne Ag | Dressings |
CS269876B1 (en) | 1987-06-22 | 1990-05-14 | Maryska Stanislav | Haemostatic non-absorbable therapeutical planary absorbent textile fabric |
GB2208277B (en) | 1987-07-30 | 1991-11-13 | Courtaulds Plc | Cellulosic fibre |
US4947840A (en) | 1987-08-21 | 1990-08-14 | Massachusetts Institute Of Technology | Biodegradable templates for the regeneration of tissues |
NZ226171A (en) | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
US4876332A (en) | 1987-10-08 | 1989-10-24 | Regents Of The Univeristy Of Minnesota | Polypeptides with type IV collagen activity |
US5277915A (en) | 1987-10-30 | 1994-01-11 | Fmc Corporation | Gel-in-matrix containing a fractured hydrogel |
JPH01130252A (en) | 1987-11-03 | 1989-05-23 | Internatl Business Mach Corp <Ibm> | Computer assembly connector |
US4919681A (en) | 1988-02-16 | 1990-04-24 | Basf Corporation | Method of preparing cellulosic fibers having increased absorbency |
WO1989008466A1 (en) | 1988-03-09 | 1989-09-21 | Terumo Kabushiki Kaisha | Medical material permitting cells to enter thereinto and artificial skin |
AU632273B2 (en) | 1988-03-09 | 1992-12-24 | Terumo Kabushiki Kaisha | Medical material permitting cells to enter thereinto and artificial skin |
US4950483A (en) | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US5024841A (en) | 1988-06-30 | 1991-06-18 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US5110604A (en) | 1988-06-30 | 1992-05-05 | Collagen Corporation | Processes for producing collagen matrixes and methods of using same |
DE3832162A1 (en) | 1988-09-22 | 1990-04-12 | Lohmann Therapie Syst Lts | METHOD FOR THE PRODUCTION OF COLLAGEN FOAMS IN THE FORM OF ENDLESS TAPES AND USE IN MEDICINE, COSMETICS AND HYGIENE |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
US5124197A (en) | 1989-07-28 | 1992-06-23 | Kimberly-Clark Corporation | Inflated cellulose fiber web possessing improved vertical wicking properties |
JPH03176064A (en) | 1989-12-05 | 1991-07-31 | Hoechst Japan Ltd | Wound surface covering material |
SE9002017D0 (en) | 1990-06-06 | 1990-06-06 | Kabivitrum Ab | PROCESS FOR MANUFACTURE OF MATRICES |
DE69132692T2 (en) | 1990-06-14 | 2002-07-04 | Integra Lifesciences I Corp | Wound dressing and catheter holder made of a polyurethane-biopolymer composite material |
CN1035803C (en) | 1990-07-24 | 1997-09-10 | 中国化工进出口总公司 | Soluble hemostyptic fabric |
FR2667246A1 (en) | 1990-10-02 | 1992-04-03 | Imedex | BIOMATERIAL BASED ON COLLAGEN AND APPLICATIONS. |
IT1249315B (en) | 1991-05-23 | 1995-02-22 | Euroresearch Srl | NON-POROUS COLLAGEN PLATE FOR THERAPEUTIC USE, METHOD AND EQUIPMENT TO OBTAIN IT |
CA2071137A1 (en) | 1991-07-10 | 1993-01-11 | Clarence C. Lee | Composition and method for revitalizing scar tissue |
CH683149A5 (en) | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Process for the preparation of microspheres of a biodegradable polymeric material. |
GB2266239B (en) | 1992-03-25 | 1996-03-06 | Jevco Ltd | Wound healing compositions containing chondroitin sulphate oligosaccharides |
GB9206509D0 (en) | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges containing active agents |
GB9206504D0 (en) | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges as wound implants |
DE4242015A1 (en) | 1992-04-02 | 1993-10-07 | Sebapharma Gmbh & Co | Wound dressing, wound dressing or carrier matrix |
CA2094658A1 (en) | 1992-04-23 | 1993-10-24 | Martin Sumner-Smith | Intracellular delivery of biochemical agents |
IL105529A0 (en) | 1992-05-01 | 1993-08-18 | Amgen Inc | Collagen-containing sponges as drug delivery for proteins |
FR2692582B1 (en) | 1992-06-18 | 1998-09-18 | Flamel Tech Sa | NEW CROSSLINKABLE DERIVATIVES OF COLLAGEN, THEIR PROCESS FOR OBTAINING IT AND THEIR APPLICATION TO THE PREPARATION OF BIOMATERIALS. |
DE4227681C2 (en) | 1992-08-21 | 1995-05-18 | Becker & Co Naturinwerk | Wound covering material based on collagen fibers and process for its production |
EP0667167B1 (en) | 1992-11-02 | 2000-02-02 | Nippon Meat Packers, Inc. | Absorbable topical hemostat |
US5491130A (en) | 1992-11-10 | 1996-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Peptide inhibitors of fibronectin and related collagen-binding proteins |
GB2272645B8 (en) | 1992-11-23 | 2010-02-10 | Johnson & Johnson Medical | Wound dressing |
GB9225581D0 (en) | 1992-12-08 | 1993-01-27 | Courtaulds Plc | Wound dressings |
FR2699184B1 (en) | 1992-12-16 | 1995-03-10 | Flamel Tech Sa | New collagen derivatives, their process for obtaining and their application to the preparation of biomaterials. |
GB2275686B (en) | 1993-03-03 | 1997-04-30 | Johnson & Johnson Medical | Swellable wound dressing materials |
GB2280850B (en) | 1993-07-28 | 1997-07-30 | Johnson & Johnson Medical | Absorbable composite materials for use in the treatment of periodontal disease |
GB2280372B (en) | 1993-07-28 | 1997-12-03 | Johnson & Johnson Medical | Composite surgical material |
AT410754B (en) | 1993-03-31 | 2003-07-25 | Nycomed Austria Gmbh | DEVICE FOR EVENLY APPLYING A SUSPENSION TO A COLLAGE CARRIER |
FR2704632B1 (en) | 1993-04-29 | 1995-06-23 | Air Liquide | PROCESS AND PLANT FOR SEPARATING AIR. |
US5405953A (en) | 1993-08-03 | 1995-04-11 | Biocontrol Incorporated | Microfibrillated oxycellulose |
JP3542170B2 (en) | 1993-08-06 | 2004-07-14 | 株式会社アムニオテック | Medical material and method for producing the same |
DK94693D0 (en) | 1993-08-19 | 1993-08-19 | Coloplast As | NON-FIBROEST POROEST MATERIALS, SPECIAL BANDING INCLUDING SUCH A BANDAGE AND PROCEDURE FOR MANUFACTURING THE MATERIAL |
GB2281861B (en) | 1993-09-21 | 1997-08-20 | Johnson & Johnson Medical | Bioabsorbable wound implant materials containing microspheres |
US5441491A (en) | 1994-02-04 | 1995-08-15 | Verschoor; Jacob | Method and composition for treating biopsy wounds |
DE4405175C2 (en) | 1994-02-18 | 1997-04-24 | Dt Membranfilter Vertrieb | Device for filtering and separating flow media by means of filter elements designed in the manner of membrane cushions |
DE4407875C2 (en) | 1994-03-04 | 1996-04-04 | Ankerpharm Gmbh Ankerwerk Rudo | Medical sponge made from bioabsorbable materials, process and device for its production |
US5599335A (en) | 1994-03-29 | 1997-02-04 | The Procter & Gamble Company | Absorbent members for body fluids having good wet integrity and relatively high concentrations of hydrogel-forming absorbent polymer |
DE4414755C2 (en) | 1994-04-27 | 2000-11-16 | Lohmann Therapie Syst Lts | Collagen preparation for the controlled delivery of active ingredients, processes and use |
FR2724951A1 (en) | 1994-09-26 | 1996-03-29 | Elysees Balzac Financiere | REGENERATED CELLULOSE-BASED MATERIALS WITH IMPROVED JAVEL WATER RESISTANCE AND PROCESS FOR THEIR PREPARATION |
US5660854A (en) * | 1994-11-28 | 1997-08-26 | Haynes; Duncan H | Drug releasing surgical implant or dressing material |
EP0743066A3 (en) | 1995-05-16 | 1998-09-30 | Mitsui Pharmaceuticals, Inc. | Wound-healing agent |
GB2301362B (en) | 1995-05-30 | 1999-01-06 | Johnson & Johnson Medical | Absorbable implant materials having controlled porosity |
US5562645A (en) | 1995-05-31 | 1996-10-08 | Kimberly-Clark Corporation | Article with soft absorbent pulp sheet |
US5677284A (en) | 1995-06-06 | 1997-10-14 | Regen Biologics, Inc. | Charged collagen particle-based delivery matrix |
US5843852A (en) | 1995-12-21 | 1998-12-01 | Kimberly-Clark Worldwide, Inc. | Absorbent structure for liquid distribution |
JP3476631B2 (en) | 1995-12-21 | 2003-12-10 | 株式会社アムニオテック | Medical material composed of human-derived natural collagen membrane |
WO1997041169A1 (en) | 1996-04-26 | 1997-11-06 | Toho Rayon Co., Ltd. | Cellulose sponge and method of manufacturing same |
GB2314842B (en) * | 1996-06-28 | 2001-01-17 | Johnson & Johnson Medical | Collagen-oxidized regenerated cellulose complexes |
GB2314840B (en) | 1996-06-28 | 2000-09-06 | Johnson & Johnson Medical | Oxidized oligosaccharides and pharmaceutical compositions |
FR2754268B1 (en) * | 1996-10-07 | 1998-12-24 | Dev Des Utilisations Du Collag | ADHESIVE COMPOSITION BASED ON MACROMOLECULAR POLYALDEHYDE AND METHOD FOR CROSSLINKING COLLAGEN OR GELATIN |
US5824007A (en) | 1996-12-03 | 1998-10-20 | Simon Fraser University | Adjustable surgical stand |
JPH10212690A (en) * | 1997-01-23 | 1998-08-11 | Oji Paper Co Ltd | Low-density body |
FR2760644B1 (en) | 1997-03-13 | 2000-01-28 | Cosmetique De Lecousse Lab | COLLAGEN COMPOSITION, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS THEREOF |
GB2329181B (en) | 1997-09-11 | 2002-03-13 | Johnson & Johnson Medical | Bioabsorbable Wound Dressing Materials |
US5985434A (en) | 1997-11-25 | 1999-11-16 | Kimberly-Clark Worldwide, Inc. | Absorbent foam |
-
2000
- 2000-05-12 US US09/570,105 patent/US6309454B1/en not_active Expired - Lifetime
-
2001
- 2001-02-27 US US09/793,825 patent/US20010045177A1/en not_active Abandoned
- 2001-03-23 GB GB0107400A patent/GB2362466B/en not_active Expired - Lifetime
- 2001-05-10 AU AU43806/01A patent/AU783184B2/en not_active Expired
- 2001-05-10 CA CA2347331A patent/CA2347331C/en not_active Expired - Lifetime
- 2001-05-11 EP EP01304248A patent/EP1153622B1/en not_active Expired - Lifetime
- 2001-05-11 JP JP2001142179A patent/JP4799758B2/en not_active Expired - Lifetime
- 2001-05-11 DE DE60106322T patent/DE60106322T2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2002058733A (en) | 2002-02-26 |
EP1153622B1 (en) | 2004-10-13 |
GB2362466B (en) | 2003-10-08 |
AU4380601A (en) | 2001-11-15 |
AU783184B2 (en) | 2005-09-29 |
US6309454B1 (en) | 2001-10-30 |
GB2362466A (en) | 2001-11-21 |
US20010045177A1 (en) | 2001-11-29 |
EP1153622A1 (en) | 2001-11-14 |
DE60106322T2 (en) | 2005-10-27 |
JP4799758B2 (en) | 2011-10-26 |
CA2347331C (en) | 2010-07-13 |
DE60106322D1 (en) | 2004-11-18 |
GB0107400D0 (en) | 2001-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2347331A1 (en) | Freeze-dried composite materials and processes for the production thereof | |
EP0140596B1 (en) | Protein/polysaccharide complexes | |
CA2435159C (en) | A method of preparing a collagen sponge | |
US7098315B2 (en) | Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge | |
RU2193897C2 (en) | Collagen-based hemostatic sponge, method for its obtaining, bandage for wounds including such a sponge and kit for preparing bandage for wounds | |
US20060201996A1 (en) | Medical graft materials with adherent extracellular matrix fibrous mass | |
Fan et al. | Morphology-controllable cellulose/chitosan sponge for deep wound hemostasis with surfactant and pore-foaming agent | |
AU2002249528A1 (en) | A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge | |
JP2001009020A (en) | Sea-origin collagen-containing collagen product having low odorous property and improved mechanical characteristics and its use as cosmetics or medicinal composition or product | |
CN109172857A (en) | A kind of outer wound compound hemostatic material and preparation method thereof | |
CN107137758B (en) | Microfiber collagen hemostatic material and preparation method thereof | |
WO2004043503A1 (en) | Thrombin-carrying bioabsorbable synthetic nonwoven fabric | |
CN100376247C (en) | Preparation of bio-membrane in use for promoting wound healing, and preparation method | |
JPH0115306B2 (en) | ||
JPS6152872A (en) | Wound covering protective tape | |
AU2010288337B2 (en) | Collagenous material | |
AU2010288338B2 (en) | Collagen pad | |
JPH0226984B2 (en) | ||
JP2989049B2 (en) | Chitosan structure and laboratory bedding using it | |
CN115737890A (en) | Plastic composite material for repairing dermis and preparation method thereof | |
CN117414462A (en) | Hemostatic granule for diffuse hemorrhage and preparation method and application thereof | |
US20130040885A1 (en) | Collagen pad | |
ZA200305591B (en) | A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20210510 |